EverGlade Consulting Plays Key Role on Industrial Base Expansion Project with $150 Million in Federal Funding Secured

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

EverGlade Consulting Plays Key Role on Industrial Base Expansion Project with $150 Million in Federal Funding Secured

PR Newswire

CHARLESTON, S.C., Aug. 19, 2022 /PRNewswire/ -- EverGlade Consulting ("EverGlade"), a national consulting firm, has successfully partnered with one of the world's leading providers of drug delivery technologies to successfully secure and manage $150 million in federal funding. The project will contribute to the global expansion of pharmaceutical lipids in the United States.

Lipids are critical components in the formulation of nucleic acid therapies and are needed for mRNA (messenger ribonucleic acid) active ingredients. The industrial based expansion project will further enable the flexible production of lipids and allow for future growth in novel mRNA-based therapies, serving applications beyond COVID-19 vaccines in infectious disease control, cancer immunotherapy, protein replacement, and gene therapy. The new facility will enable future rapid response and an extensive supply of lipids to prepare for a future pandemic, bolstering vaccine production capabilities in the United States.

The total investment for the Lipid production facility is $220 million, with the U.S. Government funding $150 million through Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA). BARDA has an increased need for domestic development, rapid manufacturing, and distribution of vaccine products to respond to 21st century health security threats, as seen most recently with COVID-19. BARDA also promotes coordinated contracting support with the support of the Department of Defense (DoD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND).

"Rebuilding the domestic supply chain is critical to not only pandemic preparedness, but our future economic security," commented Eric Jia-Sobota, Founder of EverGlade Consulting.

The construction for the IBx facility will start in early 2023 with operations commencing in 2025.

About EverGlade Consulting

EverGlade Consulting is a national consulting firm that helps clients navigate the federal landscape. We are inspired by technology-driven companies whose focus is to secure non-dilutive funding through the federal government. We offer services ranging from proposal support through the implementation of systems to comply with federal regulations at agencies including BARDA, the DOD, HHS, NIAID, and DTRA.

For additional information about EverGlade Consulting, visit:

https://www.EverGlade.com

Media Contact: [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/everglade-consulting-plays-key-role-on-industrial-base-expansion-project-with-150-million-in-federal-funding-secured-301609134.html

SOURCE EverGlade Consulting

Copyright CNW Group 2022

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).